ArticleProceedings of the National Academy of Sciences of the United States of America1996

Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.

H Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.